Rolf Claes Göran Johansson
Direttore/Membro del Consiglio presso Frigoscandia AB
Provenienza dei contatti di primo grado di Rolf Claes Göran Johansson
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Frigoscandia AB
Frigoscandia AB Air Freight/CouriersTransportation Frigoscandia AB offers national and international transport and warehousing services. The firm provides thermally-regulated logistics services. It engages in shipping and storage of fresh, chilled and frozen goods from the producer to the Nordic area and the rest of the world. The company was founded in 1948 and is headquartered in Helsingborg, Sweden.
2
| Subsidiary | Air Freight/Couriers | 2 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Rolf Claes Göran Johansson tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
Karolinska Institutet | College/University | Graduate Degree | |
Zymenex A/S
Zymenex A/S BiotechnologyHealth Technology Zymenex A/S researches and develops therapeutics for life threatening diseases. The firm commercializes novel enzyme replacement therapies for the treatment of life-threatening, rare genetic diseases. The company was founded by Jens Fogh and Pär Gellerfors in 1998 and is headquartered in Hillerod, Denmark. | Biotechnology | Chairman | |
ZEALAND PHARMA A/S | Pharmaceuticals: Major | Director/Board Member | |
AGC Biologics A/S
AGC Biologics A/S Pharmaceuticals: MajorHealth Technology AGC Biologics A/S provides contract process development and biopharmaceuticals manufacturing services worldwide. It specializes in delivering custom solutions for the scale-up and the cGMP manufacture of protein-based therapeutics for pre-clinical, clinical trials, and commercial production. Its services include cell line development, bioprocess development, formulation, and analytical testing. The company was founded by Peter Vilby, Mads Laustsen, Thomas Sandal, and Morten Munk in 2001 and is headquartered in Soeborg, Denmark. | Pharmaceuticals: Major | Director/Board Member | |
CELLECTIS S.A. | Pharmaceuticals: Major | Director/Board Member | |
University of Copenhagen | College/University | Doctorate Degree | |
F2G Ltd.
F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Warren Pharmaceuticals, Inc.
Warren Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Warren Pharmaceuticals, Inc. develops tissue-protective technologies. The company was founded by Anthony Cerami and Michael Brines on May 17, 2001 and is headquartered in Tarrytown, NY. | Pharmaceuticals: Major | Director/Board Member | |
INZILE AB (PUBL) | Motor Vehicles | Director/Board Member |
Statistiche
Distribuzione geografica
Danimarca | 6 |
Svezia | 5 |
Stati Uniti | 3 |
Francia | 2 |
Regno Unito | 2 |
Settori
Health Technology | 7 |
Consumer Services | 3 |
Commercial Services | 2 |
Finance | 2 |
Distribution Services | 2 |
Posizioni
Director/Board Member | 8 |
Chairman | 2 |
Chief Executive Officer | 2 |
Private Equity Investor | 1 |
Graduate Degree | 1 |
Contatti più connessi
Insiders | |
---|---|
Thomas Tscherning | 13 |
Peter Haveneth | 2 |
- Borsa valori
- Insiders
- Rolf Claes Göran Johansson
- Connessioni Società